Clinical Trial Update: Cohort Study to Determine the Long-Term Safety and Efficacy of Biogeneric Epoetin Treatment for Renal Anemia [Phase 3]

View source ↗

Summary

This Phase 3 trial update evaluates the long-term safety and efficacy of a biosimilar epoetin (Biogeneric Epoetin) for anemia in patients with chronic kidney di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• Biogeneric Epoetin (epoetin)

Snippet

Sponsor: Ministry of Health, Malaysia | Conditions: Chronic Kidney Disease, End-Stage Renal Failure | Phase 3 | Status: UNKNOWN